Inventor · disambiguated record
Olivier De Moor
Also filed as: DE MOOR OLIVIER
6 granted patents·7 pending applications·29 citations·filing 2007–2016
81Inventor score
Files withSUMMIT CORP PLC4WYNNE GRAHAM MICHAEL4SUMMIT THERAPEUTICS PLC2BIOMARIN IGA LTD1DAVIS PAUL JAMES1
Top patents by PatentIndex Score
13 records- 0184US8518980B2Treatment of Duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Granted Aug 27, 2013·10 cites·4 claims
- 0283US8501713B2Drug combinations for the treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Aug 6, 2013·8 cites·6 claims
- 0381US8975416B2Antibacterial compoundsDAVIS PAUL JAMES·Filed 2009·Granted Mar 10, 2015·5 cites·32 claims
- 0477US9763925B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2016·Granted Sep 19, 2017·2 cites·7 claims
- 0577US9314456B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Apr 19, 2016·2 cites·3 claims
- 0671US8138351B2Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Mar 20, 2012·2 cites·10 claims
- 0757US2011195929A1Compounds for the treatment of flaviviral infectionsSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 0853US2010048660A1Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Application pending·0 cites
- 0951US2010317607A1Use of compounds for preparing anti-tuberculosis agentsINFECTIOUS DISEASE RES INST·Filed 2008·Application pending·0 cites
- 1046US2010168072A1Drug Combinations for the Treatment of Duchenne Muscular DystrophyBIOMARIN IGA LTD·Filed 2008·Application pending·0 cites
- 1146US2011237538A1Treatment of lysosomal storage disorders and other proteostatic diseasesSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 1245US2014018320A1Treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 1345US2014011782A1Drug combinations for the treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →